dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - agenti antineoplastici - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - agenti antineoplastici - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
duloxetina almus
almus s.r.l. - duloxetina cloridrato - duloxetina cloridrato
mustela stelatopia crema lavante bebè 200ml
lab.expanscience italia srl -
colchicina pharmaselect
pharmaselect international beteiligungs gmbh - colchicina - colchicina
cyrdanax
pharmaselect international beteiligungs gmbh - dexrazoxano - dexrazoxano
enaxozar
pharmaselect international beteiligungs gmbh - dexrazoxano - dexrazoxano
colcamexx
pharmaselect international beteiligungs gmbh - colchicina - colchicina
pronto platamine
pharmachemie b.v. - cisplatino - cisplatino
colestene integratore alimentare
pharmasuisse laboratories srl -